Q3 FY2026 · ended Jun 30, 2026 · Revenue $5.55M, +20.6% YoY · Filed Aug 13, 2026
cbdMD, Inc. (YCBD) files with the SEC under industry code 2844, Perfumes, Cosmetics & Other Toilet Preparations. In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $5.6 million and a net loss of $1.1 million. Free cash flow was -$460,223. As of Jun 30, 2026 it held $2.1 million in cash and investments and $2.2 million in total debt.
Revenue
$5.55M
+20.6% vs year-ago quarter
Net income
$-1.13M
-25.9% vs year-ago quarter
Operating cash flow
$-442,158
+37.2% vs year-ago quarter
Free cash flow
$-460,223
+34.8% vs year-ago quarter
EPS
$-0.15
Dividend per share
None
Shares outstanding
11.21M
+25.7% vs year-ago quarter
Net cash
$-70,337
Q3 FY2026
Operating margin
-13.9%
TTM
Company profile
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
- Listed as
- YCBD (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NC
- Headquarters
- Charlotte, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644903
- Former names
- Level Brands, Inc. (until May 1, 2019); LEVEL BEAUTY GROUP, INC. (until Sep 27, 2016)
Other Perfumes, Cosmetics & Other Toilet Preparations companies
- Colgate Palmolive Co CL
- Haleon plc HLN
- Estee Lauder Companies Inc EL
- e.l.f. Beauty, Inc. ELF
- Interparfums Inc IPAR
- Coty Inc. COTY
- EDGEWELL PERSONAL CARE Co EPC
- Oddity Tech Ltd ODD
All 22 Perfumes, Cosmetics & Other Toilet Preparations companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
Q2 FY2025 Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.6M | $5.6M | $4.7M | $4.6M | $4.7M |
| Operating income | -$1.1M | -$800,784 | -$685,816 | -$904,686 | -$485,816 |
| Net income | -$1.1M | -$797,978 | -$679,968 | -$895,272 | -$480,757 |
| Operating cash flow | -$442,158 | -$1.5M | -$240,749 | -$704,200 | $305,038 |
| Free cash flow | -$460,223 | -$1.7M | -$243,553 | -$705,675 | $289,532 |
| Total assets | $13.1M | $12.3M | $10.4M | $9.9M | $10.9M |
| Total liabilities | $4.9M | $3.0M | $3.2M | $3.8M | $10.3M |
| Stockholders' equity | $8.2M | $9.3M | $7.2M | $6.1M | $665,798 |
| Cash and investments | $2.1M | $2.6M | $2.3M | $1.1M | $1.8M |
| Total debt | $2.2M | $407,811 | $778,240 | $962,738 | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 2, 2026 | Sep 1, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Apr 15, 2026 | Apr 14, 2026 |
All 538 cbdMD, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.